Intelligence Profile
Clinical Applications
Current clinical evidence for follistatin 315 is extremely limited, with no completed human clinical trials identified. The available research consists entirely of preclinical studies in animal models and in vitro experiments.
Potential Applications Under Investigation
Muscle Growth and Bone Health
Preclinical research suggests follistatin may influence musculoskeletal development. A 2021 study in young adult male mice demonstrated that follistatin-induced muscle growth was associated with alterations in bone geometry, indicating potential interconnections between muscle and bone development pathways.
Wound Healing and Tissue Repair
Laboratory studies from 2019 examined follistatin's effects on cellular processes relevant to tissue repair, including migration, blood vessel formation (vascularization), and bone formation (osteogenesis) both in laboratory cultures and animal models of bone repair.
Reproductive Biology
Limited research has explored follistatin's role in reproductive processes, with one 2018 study examining its effects on early embryonic development in pigs, though this application remains highly experimental.
Current Clinical Status
No human clinical trials for follistatin 315 have been completed or are currently documented in major trial databases. The compound has been detected in black market products according to a 2019 drug testing analysis, suggesting illicit use despite the absence of approved clinical applications or safety data in humans.
Evidence Limitations
The clinical potential of follistatin 315 remains largely theoretical, based solely on laboratory and animal studies. Without human clinical trials, there is no established safety profile, optimal dosing, or proven efficacy for any medical condition in humans.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Consult healthcare professionals for any medical decisions.